About Recordati Rare Diseases
Recordati Rare Diseases is a Healthcare company based in United States founded in 2012. It develops and commercializes treatments for rare diseases with global patient focus. It operates on a B2B model. Recordati Rare Diseases offers products and services including Rare Disease Treatments. Its focus areas include Biopharmaceuticals, Rare Diseases and Orphan Drugs. Its legal entity is Recordati S.p.A. Similar companies include Moderna, BridgeBio and Spark Therapeutics; 3 of its 3 listed similar companies have raised funding.
Company details
Recordati Rare Diseases is a pharmaceutical company that focuses on developing and commercializing medicines for rare diseases, including orphan drugs. They operate through global collaborations, RD pipelines, and acquisitions, with headquarters in Milan, Italy. The company emphasizes patient safety via pharmacovigilance and provides medical information to healthcare providers and patients worldwide.
- Headquarters Hunterdon, United States
- SectorsHealthcare
- Email••••••••
- Website recordatirarediseases.com
- Social LinkedIn X
- Legal Name Recordati S.P.A.
Products & Services of Recordati Rare Diseases
Recordati Rare Diseases offers a comprehensive portfolio of products and services, including Rare Disease Treatments.
Medicines for conditions like Acromegaly and Cystic Fibrosis
People of Recordati Rare Diseases
47 people are tracked at Recordati Rare Diseases (24 in leadership, 23 in team).
| Name | Role | Group |
|---|---|---|
Latoia Allen | Regional Business Director | Leadership |
Peter H. Strauss | Vice President Endocrinology & Head Of Market Access | Leadership |
Sergio Cuello | Regional Business Director | Leadership |
Chad Morris | West Area Business Director - Endocrinology | Leadership |
Richard J. Garofalo | Director, Financial Planning And Analysis | Leadership |
Angela Gatto | Human Resources Business Partner | Leadership |
Lisa Atkinson | Director Marketing, Endocrinology | Leadership |
Mohamed Ladha | President and General Manager | Leadership |
Lori Larsen | Vice President Finance | Leadership |
Peng Gu | Head Of Sales And Marketing | Leadership |
Eric Hancock | Regional Business Director, West | Leadership |
George Missailidis | Regional Business Director, West - Rare Disease | Leadership |
Joseph Bateman | Director, North American Legal And Compliance | Leadership |
Julie Demoyer Hurd | Senior Director, US Patient And Payer Access | Leadership |
Becky Z. | Vice President Human Resources | Leadership |
Leah Husi | Head Of Talent Acquisition, North America | Leadership |
Lucy Bourne McIpd | Associate HR Director UK & Ireland | Leadership |
Maxwell Johnson | General Manager | Leadership |
Yeonjae Kate L. | Head Of Asia | Leadership |
Ailyn Abin | Head Of Legal And Compliance, North America | Leadership |
27 more people are available in the full profile.
Complete people profiles for Recordati Rare Diseases
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Recordati Rare Diseases
Recordati Rare Diseases has 3 listed similar companies in our database, 3 of them funded. They include Moderna, BridgeBio and Spark Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. |
Detailed similar companies of Recordati Rare Diseases
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Recordati Rare Diseases
Websites that share an audience with Recordati Rare Diseases (recordatirarediseases.com).
Websites whose visitors overlap most with Recordati Rare Diseases. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| proclinical.com | 88% | 63.8K | #560,331 | View details | |
| chiesi.com | 75% | 112.3K | #413,363 | View details |
Top companies in Rare Diseases
3 companies that operate in the same segment as Recordati Rare Diseases (Rare Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Recordati Rare Diseases
Complete news archive for Recordati Rare Diseases
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Recordati Rare Diseases
Recordati Rare Diseases was founded in 2012.
Recordati Rare Diseases is headquartered in United States. It is registered at New Jersey, United States.
Recordati Rare Diseases is a pharmaceutical company that focuses on developing and commercializing medicines for rare diseases, including orphan drugs. They operate through global collaborations, RD pipelines, and acquisitions, with headquarters in Milan, Italy. The company emphasizes patient safety via pharmacovigilance and provides medical information to healthcare providers and patients worldwide.
Recordati Rare Diseases's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Recordati Rare Diseases offers Rare Disease Treatments.
Recordati Rare Diseases operates through Recordati S.P.A..